Skip to main content
. 2012 Jun 24;65(10):940–944. doi: 10.1136/jclinpath-2012-200773

Table 3.

Patients’ RR

KRAS WT N (%)
CR 1 (2)
PR 12 (24)
SD 15 (30)
PD 22 (44)
DCR 28 (56)
PFS (months) 4.4
OS (months) 10.4

CR, complete response; DCR, disease control rate; OS, overall survival; PD, progression disease; PFS, progression-free survival; PR, partial response; RR, response rate; SD, stable disease; WT, wild type.